市場調査レポート

商品コード

1442902

免疫療法薬市場：世界の産業分析、規模、シェア、成長、動向、および予測、2023年～2031年

Immunotherapy Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031

出版日: 2024年01月16日 | 発行: Transparency Market Research

| ページ情報: 英文 168 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　詳細はお問い合わせください。

価格

PDF (Single User License)

USD 5,795 915,030円

レポートPDFを1名のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は可能です。印刷物の取り扱いは電子版のライセンス範囲に準拠します。

PDF (Multi-user License)

USD 8,795 1,388,730円

レポートPDFを同一の部署内・課内の方にご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は可能です。印刷物の取り扱いは電子版のライセンス範囲に準拠します。

PDF (Corporate License)

USD 11,795 1,862,430円

レポートPDFを企業内すべての方に使用頂けるライセンスです。ご利用人数の制限はありません。 PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は可能です。印刷物の取り扱いは電子版のライセンス範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=157.90円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

免疫療法薬市場 - レポートの範囲

世界の免疫療法薬市場に関するTMRのレポートは、過去と現在の成長動向、および2023年から2031年の予測期間中に市場の指標の貴重な洞察を得る機会を研究しています。このレポートは、世界の免疫療法薬市場の収益を提供します。 2017年から2031年の期間、2023年を基準年、2031年を予測年とみなします。レポートは、2023年から2031年までの世界の免疫療法薬市場の複合年間成長率（CAGR %）も提供します。

このレポートは広範な調査を経て作成されました。1次調査では、調査活動の大部分が行われ、アナリストが主要なオピニオンリーダー、業界リーダー、オピニオンメーカーにインタビューを実施しました。2次調査には、免疫療法薬市場を理解するために、主要企業の製品文献、年次報告書、プレスリリース、および関連文書の参照が含まれます。

このレポートは、世界の免疫療法薬市場の競合情勢を詳しく掘り下げています。世界の免疫療法薬市場で活動する主要企業が特定され、それぞれの企業がさまざまな属性の観点からプロファイルされています。会社概要、財務状況、最近の動向、 SWOTは、このレポートで紹介されている世界の免疫療法薬市場の企業の属性です。

List of Tables

Table 01: Global Immunotherapy Drugs Market Value (US$ Mn) Forecast, by Drug Type, 2017-2031
Table 02: Global Immunotherapy Drugs Market Value (US$ Mn) Forecast, by Therapy Area, 2017-2031
Table 03: Global Immunotherapy Drugs Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2031
Table 04: Global Immunotherapy Drugs Market Value (US$ Mn) Forecast, by Region, 2017-2031
Table 05: North America Immunotherapy Drugs Market Value (US$ Mn) Forecast, by Country, 2017-2031
Table 06: North America Immunotherapy Drugs Market Value (US$ Mn) Forecast, by Drug Type, 2017-2031
Table 07: North America Immunotherapy Drugs Market Value (US$ Mn) Forecast, by Therapy Area, 2017-2031
Table 08: North America Immunotherapy Drugs Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2031
Table 09: Europe Immunotherapy Drugs Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 10: Europe Immunotherapy Drugs Market Value (US$ Mn) Forecast, by Drug Type, 2017-2031
Table 11: Europe Immunotherapy Drugs Market Value (US$ Mn) Forecast, by Therapy Area, 2017-2031
Table 12: Europe Immunotherapy Drugs Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2031
Table 13: Asia Pacific Immunotherapy Drugs Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 14: Asia Pacific Immunotherapy Drugs Market Value (US$ Mn) Forecast, by Drug Type, 2017-2031
Table 15: Asia Pacific Immunotherapy Drugs Market Value (US$ Mn) Forecast, by Therapy Area, 2017-2031
Table 16: Asia Pacific Immunotherapy Drugs Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2031
Table 17: Latin America Immunotherapy Drugs Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 18: Latin America Immunotherapy Drugs Market Value (US$ Mn) Forecast, by Drug Type, 2017-2031
Table 19: Latin America Immunotherapy Drugs Market Value (US$ Mn) Forecast, by Therapy Area, 2017-2031
Table 20: Latin America Immunotherapy Drugs Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2031
Table 21: Middle East & Africa Immunotherapy Drugs Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 22: Middle East & Africa Immunotherapy Drugs Market Value (US$ Mn) Forecast, by Drug Type, 2017-2031
Table 23: Middle East & Africa Immunotherapy Drugs Market Value (US$ Mn) Forecast, by Therapy Area, 2017-2031
Table 24: Middle East & Africa Immunotherapy Drugs Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2031

List of Figures

Figure 01: Global Immunotherapy Drugs Market Value (US$ Mn) Forecast, 2017-2031
Figure 02: Global Immunotherapy Drugs Market Value Share, by Region, 2022
Figure 03: Global Immunotherapy Drugs Market Value Share, by Drug Type, 2022
Figure 04: Global Immunotherapy Drugs Market Value Share, by Therapy Area, 2022
Figure 05: Global Immunotherapy Drugs Market Value Share, by Distribution Channel, 2022
Figure 06: Global Immunotherapy Drugs Market Value Share Analysis, by Drug Type, 2022 and 2031
Figure 07: Global Immunotherapy Drugs Market Value Share Analysis, by Drug Type, 2022
Figure 08: Global Immunotherapy Drugs Market Value Share Analysis, by Drug Type, 2031
Figure 09: Global Immunotherapy Drugs Market Attractiveness Analysis, by Drug Type, 2023-2031
Figure 10: Global Immunotherapy Drugs Market Value (US$ Mn), by Monoclonal Antibodies, 2017-2031
Figure 11: Global Immunotherapy Drugs Market Value Share Analysis, by Monoclonal Antibodies, 2022 and 2031
Figure 12: Global Immunotherapy Drugs Market Value (US$ Mn), by Immunomodulators, 2017-2031
Figure 13: Global Immunotherapy Drugs Market Value Share Analysis, by Immunomodulators, 2022 and 2031
Figure 14: Global Immunotherapy Drugs Market Value (US$ Mn), by Cell Therapy, 2017-2031
Figure 15: Global Immunotherapy Drugs Market Value Share Analysis, by Cell Therapy, 2022 and 2031
Figure 16: Global Immunotherapy Drugs Market Value (US$ Mn), by Others, 2017-2031
Figure 17: Global Immunotherapy Drugs Market Value Share Analysis, by Others, 2022 and 2031
Figure 18: Global Immunotherapy Drugs Market Value Share Analysis, by Therapy Area, 2022 and 2031
Figure 19: Global Immunotherapy Drugs Market Value Share Analysis, by Therapy Area, 2022
Figure 20: Global Immunotherapy Drugs Market Value Analysis, by Therapy Area, 2031
Figure 21: Global Immunotherapy Drugs Market Attractiveness Analysis, by Therapy Area, 2023-2031
Figure 22: Global Immunotherapy Drugs Market Value (US$ Mn), by Cancer, 2017-2031
Figure 23: Global Immunotherapy Drugs Market Value Share Analysis, by Cancer, 2022 and 2031
Figure 24: Global Immunotherapy Drugs Market Value (US$ Mn), by Autoimmune Diseases, 2017-2031
Figure 24: Global Immunotherapy Drugs Market Value Share Analysis, by Autoimmune Diseases, 2022 and 2031
Figure 25: Global Immunotherapy Drugs Market Value (US$ Mn), by Autoimmune Diseases, 2017-2031
Figure 25: Global Immunotherapy Drugs Market Value Share Analysis, by Autoimmune Diseases, 2022 and 2031
Figure 26: Global Immunotherapy Drugs Market Value (US$ Mn), by Others, 2017-2031
Figure 27: Global Immunotherapy Drugs Market Value Share Analysis, by Others, 2022 and 2031
Figure 28: Global Immunotherapy Drugs Market Value Share Analysis, by Distribution Channel, 2022 and 2031
Figure 29: Global Immunotherapy Drugs Market Value Share Analysis, by Distribution Channel, 2022
Figure 30: Global Immunotherapy Drugs Market Value Share Analysis, by Distribution Channel, 2031
Figure 31: Global Immunotherapy Drugs Market Attractiveness Analysis, by Distribution Channel, 2023-2031
Figure 32: Global Immunotherapy Drugs Market Value (US$ Mn), by Retail Pharmacies, 2017-2031
Figure 33: Global Immunotherapy Drugs Market Value Share Analysis, by Retail Pharmacies, 2022 and 2031
Figure 34: Global Immunotherapy Drugs Market Value (US$ Mn), by Online Pharmacies, 2017-2031
Figure 35: Global Immunotherapy Drugs Market Value Share Analysis, by Online Pharmacies, 2022 and 2031
Figure 36: Global Immunotherapy Drugs Market Value (US$ Mn), by Hospital Pharmacies, 2017-2031
Figure 36: Global Immunotherapy Drugs Market Value Share Analysis, by Hospital Pharmacies, 2022 and 2031
Figure 37: Global Immunotherapy Drugs Market Value Share Analysis, by Region, 2022 and 2031
Figure 38: Global Immunotherapy Drugs Market Value Share Analysis, by Region, 2022
Figure 39: Global Immunotherapy Drugs Market Value Analysis, by Region, 2031
Figure 40: Global Immunotherapy Drugs Market Attractiveness Analysis, by Region, 2023-2031
Figure 41: North America Immunotherapy Drugs Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
Figure 42: North America Immunotherapy Drugs Market Value Share Analysis, by Country, 2022 and 2031
Figure 43: North America Immunotherapy Drugs Market Attractiveness Analysis, by Country, 2023-2031
Figure 44: North America Immunotherapy Drugs Market Value (US$ Mn) Share Analysis, by Drug Type, 2022 and 2031
Figure 45: North America Immunotherapy Drugs Market Value (US$ Mn) Share Analysis, by Drug Type, 2022
Figure 46: North America Immunotherapy Drugs Market Attractiveness Analysis, by Drug Type, 2023-2031
Figure 47: North America Immunotherapy Drugs Market Value (US$ Mn) Share Analysis, by Therapy Area, 2022 and 2031
Figure 48: North America Immunotherapy Drugs Market Value (US$ Mn) Share Analysis, by Therapy Area, 2022
Figure 49: North America Immunotherapy Drugs Market Attractiveness Analysis, by Therapy Area, 2023-2031
Figure 50: North America Immunotherapy Drugs Market Value (US$ Mn) Share Analysis, by Distribution Channel, 2022 and 2031
Figure 51: North America Immunotherapy Drugs Market Value (US$ Mn) Share Analysis, by Distribution Channel, 2022
Figure 52: North America Immunotherapy Drugs Market Attractiveness Analysis, by Distribution Channel, 2023-2031
Figure 53: Europe Immunotherapy Drugs Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
Figure 54: Europe Immunotherapy Drugs Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 55: Europe Immunotherapy Drugs Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
Figure 56: Europe Immunotherapy Drugs Market Value (US$ Mn) Share Analysis, by Drug Type, 2022 and 2031
Figure 57: Europe Immunotherapy Drugs Market Value (US$ Mn) Share Analysis, by Drug Type, 2022
Figure 58: Europe Immunotherapy Drugs Market Attractiveness Analysis, by Drug Type, 2023-2031
Figure 59: Europe Immunotherapy Drugs Market Value (US$ Mn) Share Analysis, by Therapy Area, 2022 and 2031
Figure 60: Europe Immunotherapy Drugs Market Value (US$ Mn) Share Analysis, by Therapy Area, 2022
Figure 61: Europe Immunotherapy Drugs Market Attractiveness Analysis, by Therapy Area, 2023-2031
Figure 62: Europe Immunotherapy Drugs Market Value (US$ Mn) Share Analysis, by Distribution Channel, 2022 and 2031
Figure 63: Europe Immunotherapy Drugs Market Value (US$ Mn) Share Analysis, by Distribution Channel, 2022
Figure 64: Europe Immunotherapy Drugs Market Attractiveness Analysis, by Distribution Channel, 2023-2031
Figure 65: Asia Pacific Immunotherapy Drugs Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
Figure 66: Asia Pacific Immunotherapy Drugs Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 67: Asia Pacific Immunotherapy Drugs Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
Figure 68: Asia Pacific Immunotherapy Drugs Market Value (US$ Mn) Share Analysis, by Drug Type, 2022 and 2031
Figure 69: Asia Pacific Immunotherapy Drugs Market Value (US$ Mn) Share Analysis, by Drug Type, 2022
Figure 70: Asia Pacific Immunotherapy Drugs Market Attractiveness Analysis, by Drug Type, 2023-2031
Figure 71: Asia Pacific Immunotherapy Drugs Market Value (US$ Mn) Share Analysis, by Therapy Area, 2022 and 2031
Figure 72: Asia Pacific Immunotherapy Drugs Market Value (US$ Mn) Share Analysis, by Therapy Area, 2022
Figure 73: Asia Pacific Immunotherapy Drugs Market Attractiveness Analysis, by Therapy Area, 2023-2031
Figure 74: Asia Pacific Immunotherapy Drugs Market Value (US$ Mn) Share Analysis, by Distribution Channel, 2022 and 2031
Figure 75: Asia Pacific Immunotherapy Drugs Market Value (US$ Mn) Share Analysis, by Distribution Channel, 2022
Figure 76: Asia Pacific Immunotherapy Drugs Market Attractiveness Analysis, by Distribution Channel, 2023-2031
Figure 77: Latin America Immunotherapy Drugs Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
Figure 78: Latin America Immunotherapy Drugs Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 79: Latin America Immunotherapy Drugs Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
Figure 80: Latin America Immunotherapy Drugs Market Value (US$ Mn) Share Analysis, by Drug Type, 2022 and 2031
Figure 81: Latin America Immunotherapy Drugs Market Value (US$ Mn) Share Analysis, by Drug Type, 2022
Figure 82: Latin America Immunotherapy Drugs Market Attractiveness Analysis, by Drug Type, 2023-2031
Figure 83: Latin America Immunotherapy Drugs Market Value (US$ Mn) Share Analysis, by Therapy Area, 2022 and 2031
Figure 84: Latin America Immunotherapy Drugs Market Value (US$ Mn) Share Analysis, by Therapy Area, 2022
Figure 85: Latin America Immunotherapy Drugs Market Attractiveness Analysis, by Therapy Area, 2023-2031
Figure 86: Latin America Immunotherapy Drugs Market Value (US$ Mn) Share Analysis, by Distribution Channel, 2022 and 2031
Figure 87: Latin America Immunotherapy Drugs Market Value (US$ Mn) Share Analysis, by Distribution Channel, 2022
Figure 88: Latin America Immunotherapy Drugs Market Attractiveness Analysis, by Distribution Channel, 2023-2031
Figure 89 Middle East & Africa Immunotherapy Drugs Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
Figure 90: Middle East & Africa Immunotherapy Drugs Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 91: Middle East & Africa Immunotherapy Drugs Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
Figure 92: Middle East & Africa Immunotherapy Drugs Market Value (US$ Mn) Share Analysis, by Drug Type, 2022 and 2031
Figure 93: Middle East & Africa Immunotherapy Drugs Market Value (US$ Mn) Share Analysis, by Drug Type, 2022
Figure 94: Middle East & Africa Immunotherapy Drugs Market Attractiveness Analysis, by Drug Type, 2023-2031
Figure 95: Middle East & Africa Immunotherapy Drugs Market Value (US$ Mn) Share Analysis, by Therapy Area, 2022 and 2031
Figure 96: Middle East & Africa Immunotherapy Drugs Market Attractiveness Analysis, by Therapy Area, 2023-2031
Figure 97: Middle East & Africa Immunotherapy Drugs Market Value (US$ Mn) Share Analysis, by Therapy Area, 2022
Figure 98: Middle East & Africa Immunotherapy Drugs Market Value (US$ Mn) Share Analysis, by Distribution Channel, 2022 and 2031
Figure 99: Middle East & Africa Immunotherapy Drugs Market Attractiveness Analysis, by Distribution Channel, 2023-2031
Figure 100: Middle East & Africa Immunotherapy Drugs Market Value (US$ Mn) Share Analysis, by Distribution Channel, 2022

Product Code: TMRGL23771

Immunotherapy Drugs Market - Scope of Report

TMR's report on the global immunotherapy drugs market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global immunotherapy drugs market for the period 2017-2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global immunotherapy drugs market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the immunotherapy drugs market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global immunotherapy drugs market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global immunotherapy drugs market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global immunotherapy drugs market.

The report delves into the competitive landscape of the global immunotherapy drugs market. Key players operating in the global immunotherapy drugs market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global immunotherapy drugs market profiled in this report.

Key Questions Answered in Global immunotherapy drugs Market Report:

What is the sales/revenue generated by immunotherapy drugs across all regions during the forecast period?
What are the opportunities in the global immunotherapy drugs market?
What are the major drivers, restraints, opportunities, and threats in the market?
Which regional market is set to expand at the fastest CAGR during the forecast period?
Which segment is expected to generate the highest revenue globally in 2031?
Which segment is projected to expand at the highest CAGR during the forecast period?
What are the market positions of different companies operating in the global market?

Immunotherapy Drugs Market - Research Objectives and Research Approach

The comprehensive report on the global immunotherapy drugs market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global immunotherapy drugs market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global immunotherapy drugs market.

1. Preface

1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Immunotherapy Drugs Market

4. Market Overview

4.1. Introduction
- 4.1.1. Segment Definition
- 4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
- 4.3.1. Drivers
- 4.3.2. Restraints
- 4.3.3. Opportunities
- 4.3.4. Global Immunotherapy Drugs Market Analysis and Forecast, 2017-2031

5. Key Insights

5.1. Pipeline Analysis
5.2. Key Industry Events
5.3. COVID-19 Impact Analysis

6. Global Immunotherapy Drugs Market Analysis and Forecast, by Drug Type

6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Drug Type, 2017-2031
- 6.3.1. Monoclonal Antibodies
- 6.3.2. Immunomodulators
- 6.3.3. Cell Therapy
- 6.3.4. Others (Vaccines, etc.)
6.4. Market Attractiveness Analysis, by Drug Type

7. Global Immunotherapy Drugs Market Analysis and Forecast, by Therapy Area

7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Therapy Area, 2017-2031
- 7.3.1. Cancer
- 7.3.2. Autoimmune Diseases
- 7.3.3. Infectious Diseases
- 7.3.4. Others
7.4. Market Attractiveness Analysis, by Therapy Area

8. Global Immunotherapy Drugs Market Analysis and Forecast, by Distribution Channel

8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast, by Distribution Channel, 2017-2031
- 8.3.1. Retail Pharmacies
- 8.3.2. Online Pharmacies
- 8.3.3. Hospital Pharmacies

9. Global Immunotherapy Drugs Market Analysis and Forecast, by Region

9.1. Key Findings
9.2. Market Value Forecast, by Region
- 9.2.1. North America
- 9.2.2. Europe
- 9.2.3. Asia Pacific
- 9.2.4. Latin America
- 9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Region

10. North America Immunotherapy Drugs Market Analysis and Forecast

10.1. Introduction
- 10.1.1. Key Findings
10.2. Market Value Forecast, by Drug Type, 2017-2031
- 10.2.1. Monoclonal Antibodies
- 10.2.2. Immunomodulators
- 10.2.3. Cell Therapy
- 10.2.4. Others (Vaccines, etc.)
10.3. Market Value Forecast, by Therapy Area, 2017-2031
- 10.3.1. Cancer
- 10.3.2. Autoimmune Diseases
- 10.3.3. Infectious Diseases
- 10.3.4. Others
10.4. Market Value Forecast, by Distribution Channel, 2017-2031
- 10.4.1. Retail Pharmacies
- 10.4.2. Online Pharmacies
- 10.4.3. Hospital Pharmacies
10.5. Market Attractiveness Analysis
- 10.5.1. By Drug Type
- 10.5.2. By Therapy Area
- 10.5.3. By Distribution Channel
- 10.5.4. By Country

11. Europe Immunotherapy Drugs Market Analysis and Forecast

11.1. Introduction
- 11.1.1. Key Findings
11.2. Market Value Forecast, by Drug Type, 2017-2031
- 11.2.1. Monoclonal Antibodies
- 11.2.2. Immunomodulators
- 11.2.3. Cell Therapy
- 11.2.4. Others (Vaccines, etc.)
11.3. Market Value Forecast, by Therapy Area, 2017-2031
- 11.3.1. Cancer
- 11.3.2. Autoimmune Diseases
- 11.3.3. Infectious Diseases
- 11.3.4. Others
11.4. Market Value Forecast, by Distribution Channel, 2017-2031
- 11.4.1. Retail Pharmacies
- 11.4.2. Online Pharmacies
- 11.4.3. Hospital Pharmacies
11.5. Market Value Forecast, by Country/Sub-region, 2017-2031
- 11.5.1. Germany
- 11.5.2. U.K.
- 11.5.3. France
- 11.5.4. Spain
- 11.5.5. Italy
- 11.5.6. Rest of Europe
11.6. Market Attractiveness Analysis
- 11.6.1. By Drug Type
- 11.6.2. By Therapy Area
- 11.6.3. By Distribution Channel
- 11.6.4. By Country/Sub-region

12. Asia Pacific Immunotherapy Drugs Market Analysis and Forecast

12.1. Introduction
- 12.1.1. Key Findings
12.2. Market Value Forecast, by Drug Type, 2017-2031
- 12.2.1. Monoclonal Antibodies
- 12.2.2. Immunomodulators
- 12.2.3. Cell Therapy
- 12.2.4. Others (Vaccines, etc.)
12.3. Market Value Forecast, by Therapy Area, 2017-2031
- 12.3.1. Cancer
- 12.3.2. Autoimmune Diseases
- 12.3.3. Infectious Diseases
- 12.3.4. Others
12.4. Market Value Forecast, by Distribution Channel, 2017-2031
- 12.4.1. Retail Pharmacies
- 12.4.2. Online Pharmacies
- 12.4.3. Hospital Pharmacies
12.5. Market Value Forecast, by Country/Sub-region, 2017-2031
- 12.5.1. China
- 12.5.2. Japan
- 12.5.3. India
- 12.5.4. Australia & New Zealand
- 12.5.5. Rest of Asia Pacific
12.6. Market Attractiveness Analysis
- 12.6.1. By Drug Type
- 12.6.2. By Therapy Area
- 12.6.3. By Distribution Channel
- 12.6.4. By Country/Sub-region

13. Latin America Immunotherapy Drugs Market Analysis and Forecast

13.1. Introduction
- 13.1.1. Key Findings
13.2. Market Value Forecast, by Drug Type, 2017-2031
- 13.2.1. Monoclonal Antibodies
- 13.2.2. Immunomodulators
- 13.2.3. Cell Therapy
- 13.2.4. Others (Vaccines, etc.)
13.3. Market Value Forecast, by Therapy Area, 2017-2031
- 13.3.1. Cancer
- 13.3.2. Autoimmune Diseases
- 13.3.3. Infectious Diseases
- 13.3.4. Others
13.4. Market Value Forecast, by Distribution Channel, 2017-2031
- 13.4.1. Retail Pharmacies
- 13.4.2. Online Pharmacies
- 13.4.3. Hospital Pharmacies
13.5. Market Value Forecast, by Country/Sub-region, 2017-2031
- 13.5.1. Brazil
- 13.5.2. Mexico
- 13.5.3. Rest of Latin America
13.6. Market Attractiveness Analysis
- 13.6.1. By Drug Type
- 13.6.2. By Therapy Area
- 13.6.3. By Distribution Channel
- 13.6.4. By Country/Sub-region

14. Middle East & Africa Immunotherapy Drugs Market Analysis and Forecast

14.1. Introduction
- 14.1.1. Key Findings
14.2. Market Value Forecast, by Drug Type, 2017-2031
- 14.2.1. Monoclonal Antibodies
- 14.2.2. Immunomodulators
- 14.2.3. Cell Therapy
- 14.2.4. Others (Vaccines, etc.)
14.3. Market Value Forecast, by Therapy Area, 2017-2031
- 14.3.1. Cancer
- 14.3.2. Autoimmune Diseases
- 14.3.3. Infectious Diseases
- 14.3.4. Others
14.4. Market Value Forecast, by Distribution Channel, 2017-2031
- 14.4.1. Retail Pharmacies
- 14.4.2. Online Pharmacies
- 14.4.3. Hospital Pharmacies
14.5. Market Value Forecast, by Country/Sub-region, 2017-2031
- 14.5.1. GCC Countries
- 14.5.2. South Africa
- 14.5.3. Rest of Middle East & Africa
14.6. Market Attractiveness Analysis
- 14.6.1. By Drug Type
- 14.6.2. By Therapy Area
- 14.6.3. By Distribution Channel
- 14.6.4. By Country/Sub-region

15. Competition Landscape

15.1. Global Immunotherapy Drugs Market, Company Share Analysis (2022)
15.2. Company Profiles
- 15.2.1. Bristol Myers Squibb
  - 15.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)
  - 15.2.1.2. Product Portfolio
  - 15.2.1.3. Financial Overview
  - 15.2.1.4. SWOT Analysis
  - 15.2.1.5. Strategic Overview
- 15.2.2. Merck KGaA, Inc.
  - 15.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)
  - 15.2.2.2. Product Portfolio
  - 15.2.2.3. Financial Overview
  - 15.2.2.4. SWOT Analysis
  - 15.2.2.5. Strategic Overview
- 15.2.3. Novartis AG
  - 15.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)
  - 15.2.3.2. Product Portfolio
  - 15.2.3.3. Financial Overview
  - 15.2.3.4. SWOT Analysis
  - 15.2.3.5. Strategic Overview
- 15.2.4. AstraZeneca
  - 15.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)
  - 15.2.4.2. Product Portfolio
  - 15.2.4.3. Financial Overview
  - 15.2.4.4. SWOT Analysis
  - 15.2.4.5. Strategic Overview
- 15.2.5. Pfizer
  - 15.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)
  - 15.2.5.2. Product Portfolio
  - 15.2.5.3. Financial Overview
  - 15.2.5.4. SWOT Analysis
  - 15.2.5.5. Strategic Overview
- 15.2.6. Amgen
  - 15.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)
  - 15.2.6.2. Product Portfolio
  - 15.2.6.3. Financial Overview
  - 15.2.6.4. SWOT Analysis
  - 15.2.6.5. Strategic Overview
- 15.2.7. Gilead Sciences
  - 15.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)
  - 15.2.7.2. Product Portfolio
  - 15.2.7.3. Financial Overview
  - 15.2.7.4. SWOT Analysis
  - 15.2.7.5. Strategic Overview
- 15.2.8. Regeneron Pharmaceuticals Inc.
  - 15.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)
  - 15.2.8.2. Product Portfolio
  - 15.2.8.3. Financial Overview
  - 15.2.8.4. SWOT Analysis
  - 15.2.8.5. Strategic Overview
- 15.2.9. F. Hoffmann-La Roche AG
  - 15.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)
  - 15.2.9.2. Product Portfolio
  - 15.2.9.3. Financial Overview
  - 15.2.9.4. SWOT Analysis
  - 15.2.9.5. Strategic Overview
- 15.2.10. Eli Lilly and Company
  - 15.2.10.1. Company Overview (HQ, Business Segments, Employee Strength)
  - 15.2.10.2. Product Portfolio
  - 15.2.10.3. Financial Overview
  - 15.2.10.4. SWOT Analysis
  - 15.2.10.5. Strategic Overview

免疫療法薬市場：世界の産業分析、規模、シェア、成長、動向、および予測、2023年～2031年

Immunotherapy Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031

免疫療法薬市場 - レポートの範囲

目次

第1章序文

第2章前提条件と調査手法

第3章エグゼクティブサマリー：世界市場

第4章市場概要

第5章重要な洞察

第6章世界市場の分析と予測：医薬品タイプ別

第7章世界市場の分析と予測：治療分野別

第8章世界市場の分析と予測：流通チャネル別

第9章世界市場の分析と予測：地域別

第10章北米市場の分析と予測

第11章欧州市場の分析と予測

第12章アジア太平洋市場の分析と予測

第13章ラテンアメリカ市場の分析と予測

第14章中東・アフリカ市場の分析と予測

第15章競合情勢

List of Tables

List of Figures

Immunotherapy Drugs Market - Scope of Report

Key Questions Answered in Global immunotherapy drugs Market Report:

Immunotherapy Drugs Market - Research Objectives and Research Approach

Table of Contents

1. Preface

2. Assumptions and Research Methodology

3. Executive Summary: Global Immunotherapy Drugs Market

4. Market Overview

5. Key Insights

6. Global Immunotherapy Drugs Market Analysis and Forecast, by Drug Type

7. Global Immunotherapy Drugs Market Analysis and Forecast, by Therapy Area

8. Global Immunotherapy Drugs Market Analysis and Forecast, by Distribution Channel

9. Global Immunotherapy Drugs Market Analysis and Forecast, by Region

10. North America Immunotherapy Drugs Market Analysis and Forecast

11. Europe Immunotherapy Drugs Market Analysis and Forecast

12. Asia Pacific Immunotherapy Drugs Market Analysis and Forecast

13. Latin America Immunotherapy Drugs Market Analysis and Forecast

14. Middle East & Africa Immunotherapy Drugs Market Analysis and Forecast

15. Competition Landscape

免疫療法薬市場：世界の産業分析、規模、シェア、成長、動向、および予測、2023年～2031年

Immunotherapy Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031

免疫療法薬市場 - レポートの範囲

目次

第1章 序文

第2章 前提条件と調査手法

第3章 エグゼクティブサマリー：世界市場

第4章 市場概要

第5章 重要な洞察

第6章 世界市場の分析と予測：医薬品タイプ別

第7章 世界市場の分析と予測：治療分野別

第8章 世界市場の分析と予測：流通チャネル別

第9章 世界市場の分析と予測：地域別

第10章 北米市場の分析と予測

第11章 欧州市場の分析と予測

第12章 アジア太平洋市場の分析と予測

第13章 ラテンアメリカ市場の分析と予測

第14章 中東・アフリカ市場の分析と予測

第15章 競合情勢

List of Tables

List of Figures

Immunotherapy Drugs Market - Scope of Report

Key Questions Answered in Global immunotherapy drugs Market Report:

Immunotherapy Drugs Market - Research Objectives and Research Approach

Table of Contents

1. Preface

2. Assumptions and Research Methodology

3. Executive Summary: Global Immunotherapy Drugs Market

4. Market Overview

5. Key Insights

6. Global Immunotherapy Drugs Market Analysis and Forecast, by Drug Type

7. Global Immunotherapy Drugs Market Analysis and Forecast, by Therapy Area

8. Global Immunotherapy Drugs Market Analysis and Forecast, by Distribution Channel

9. Global Immunotherapy Drugs Market Analysis and Forecast, by Region

10. North America Immunotherapy Drugs Market Analysis and Forecast

11. Europe Immunotherapy Drugs Market Analysis and Forecast

12. Asia Pacific Immunotherapy Drugs Market Analysis and Forecast

13. Latin America Immunotherapy Drugs Market Analysis and Forecast

14. Middle East & Africa Immunotherapy Drugs Market Analysis and Forecast

15. Competition Landscape

第1章序文

第2章前提条件と調査手法

第3章エグゼクティブサマリー：世界市場

第4章市場概要

第5章重要な洞察

第6章世界市場の分析と予測：医薬品タイプ別

第7章世界市場の分析と予測：治療分野別

第8章世界市場の分析と予測：流通チャネル別

第9章世界市場の分析と予測：地域別

第10章北米市場の分析と予測

第11章欧州市場の分析と予測

第12章アジア太平洋市場の分析と予測

第13章ラテンアメリカ市場の分析と予測

第14章中東・アフリカ市場の分析と予測

第15章競合情勢